Vinge has advised Bactiguard Holding AB on the deal.
The board of directors of Bactiguard Holding AB (publ) has resolved on a directed new share issue of 1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million.
Through the directed new share issue, the total number of shares will increase by 1,500,000, from 33,543,885 to 35,043,885, corresponding to approximately 4.3 percent of the total number of shares in Bactiguard after the directed new share issue. The total number of votes in Bactiguard will increase by 1,500,000, from 69,543,885 to 71,043,885 after the directed new share issue. The share capital increases with SEK 37,500, from SEK 838,597.125 to SEK 876,097.125.
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.
The Vinge team included Erik Sjöman (Picture), Christian Lindhé and Agaton Lindgren.
Law Firms: Vinge;
Clients: Bactiguard AB;